DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer

International Journal of Oncology

Volumn 35, Issue 3, 2009, Pages 467-476

  Kato, Kuniyuki ^a   Maesawa, Chihaya ^a   Itabashi, Tetsuya ^a   Fujisawa, Kentaro ^a   Otsuka, Koki ^a   Kanno, Shoji ^a   Tada, Hiroshi ^a   Tatemichi, Yoshinori ^a   Kotani, Koji ^a   Oikawa, Hiroki ^a   Sugai, Tamotsu ^a   Wakabayashi, Go ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Colon cancer; DNA methylation; Epigenetics; L1 cell adhesion molecule gene; Metastasis

Indexed keywords

CELL ADHESION MOLECULE; L1 CELL ADHESION MOLECULE; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADVANCED CANCER; ARTICLE; BINDING SITE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISTANT METASTASIS; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SURVIVAL RATE;

BLOTTING, WESTERN; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; NEOPLASM STAGING; NEURAL CELL ADHESION MOLECULE L1; PROGNOSIS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 70349129602     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000358     Document Type: Article

References (40)

1. McCormick D, Kibbe PJ and Morgan SW: Colon cancer: prevention, diagnosis, treatment. Gastroenterol Nurs 25: 204-211; quiz, 211-202, 2002.
2. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P and Hamelin R: Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20: 5025-5032, 2001.
3. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T and Ben-Ze'ev A: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
4. Moos M, Tacke R, Scherer H, Teplow D, Fruh K and Schachner M: Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334: 701-703, 1988.
5. Schachner M: Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 9: 627-634, 1997.
6. Hortsch M: Structural and functional evolution of the L1 family: are four adhesion molecules better than one? Mol Cell Neurosci 15: 1-10, 2000.
7. Huszar M, Moldenhauer G, Gschwend V, Ben-Arie A, Altevogt P and Fogel M: Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Hum Pathol 37: 1000-1008, 2006.
8. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M and Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 279: 28880-28888, 2004.
9. Ebeling O, Duczmal A, Aigner S, Geiger C, Schollhammer S, Kemshead JT, Moller P, Schwartz-Albiez R and Altevogt P: L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur J Immunol 26: 2508-2516, 1996.
10. Debiec H, Christensen EI and Ronco PM: The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. J Cell Biol 143: 2067-2079, 1998.
11. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M and Altevogt P: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003.
12. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 11: 1190-1197, 2005.
13. Thies A, Berlin A, Brunner G, Schulze HJ, Moll I, Pfuller U, Wagener C, Schachner M, Altevogt P and Schumacher U: Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases. Cancer Lett 248: 68-80, 2007.
14. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E and Ben-Ze'ev A: Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67: 7703-7712, 2007.
15. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, Strate T, Schneider C, Pantel K, Schachner M, Sauter G and Izbicki JR: L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20: 1183-1190, 2007.
16. Wong JJ, Hawkins NJ and Ward RL: Colorectal cancer: a model for epigenetic tumorigenesis. Gut 56: 140-148, 2007.
17. Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-190, 1985.
18. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N and Ward R: The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 162: 1361-1371, 2003.
19. Ji W, Hernandez R, Zhang XY, Qu GZ, Frady A, Varela M and Ehrlich M: DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 379: 33-41, 1997.
20. Qu GZ, Grundy PE, Narayan A and Ehrlich M: Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 109: 34-39, 1999.
21. Nakamura N and Takenaga K: Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 16: 471-479, 1998.
22. Akiyama Y, Maesawa C, Ogasawara S, Terashima M and Masuda T: Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163: 1911-1919, 2003.
23. Murai S, Maesawa C, Masuda T and Sugiyama T: Aberrant maspin expression in human endometrial cancer. Cancer Sci 97: 883-888, 2006.
24. Nakamura S, Goto J, Kitayama M and Kino I: Application of the crypt-isolation technique to flow-cytometric analysis of DNA content in colorectal neoplasms. Gastroenterology 106: 100-107, 1994.
25. Ogasawara S, Maesawa C, Yamamoto M, Akiyama Y, Wada K, Fujisawa K, Higuchi T, Tomisawa Y, Sato N, Endo S, Saito K and Masuda T: Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers. Oncogene 23: 1117-1124, 2004.
26. Tokita T, Maesawa C, Kimura T, Kotani K, Takahashi K, Akasaka T and Masuda T: Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol 30: 689-694, 2007.
27. Kallunki P, Edelman GM and Jones FS: Tissue-specific expression of the L1 cell adhesion molecule is modulated by the neural restrictive silencer element. J Cell Biol 138: 1343-1354, 1997.
28. Meech R, Kallunki P, Edelman GM and Jones FS: A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins. Proc Natl Acad Sci USA 96: 2420-2425, 1999.
29. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999.
30. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
31. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
32. Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Lae M, Louvard D, Ben-Ze'ev A and Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853, 2007.
33. Vignjevic D, Yarar D, Welch MD, Peloquin J, Svitkina T and Borisy GG: Formation of filopodia-like bundles in vitro from a dendritic network. J Cell Biol 160: 951-962, 2003.
34. Yamashiro S, Yamakita Y, Ono S and Matsumura F: Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 9: 993-1006, 1998.
35. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M and Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162: 69-80, 2003.
36. Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37: 1787-1804, 2005.
37. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G and Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6: 241, 2006.
38. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749, 2005.
39. Arai M, Yokosuka O, Hirasawa Y, Fukai K, Chiba T, Imazeki F, Kanda T, Yatomi M, Takiguchi Y, Seki N, Saisho H and Ochiai T: Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine. Cancer 106: 2514-2525, 2006.
40. Domann FE and Futscher BW: Flipping the epigenetic switch. Am J Pathol 164: 1883-1886, 2004.